Olin (NYSE:OLN) Given New $78.00 Price Target at KeyCorp

Olin (NYSE:OLN - Free Report) had its price target increased by KeyCorp from $66.00 to $78.00 in a research note issued to investors on Tuesday, Benzinga reports. They currently have an overweight rating on the specialty chemicals company's stock.

Several other research analysts have also recently issued reports on OLN. Royal Bank of Canada upped their price target on Olin from $58.00 to $64.00 and gave the company an outperform rating in a report on Monday, January 29th. Stifel Nicolaus upped their price target on Olin from $65.00 to $66.00 and gave the company a buy rating in a report on Monday, January 29th. Wells Fargo & Company upped their price target on Olin from $56.00 to $60.00 and gave the company an equal weight rating in a report on Wednesday, April 3rd. Barclays upped their price target on Olin from $57.00 to $59.00 and gave the company an equal weight rating in a report on Thursday, April 4th. Finally, UBS Group upped their price target on Olin from $56.00 to $58.00 and gave the company a neutral rating in a report on Friday, January 26th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of Hold and an average price target of $57.87.

Olin Stock Performance

Shares of NYSE OLN traded up $0.32 during midday trading on Tuesday, hitting $58.70. 498,424 shares of the company's stock were exchanged, compared to its average volume of 1,051,064. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.29 and a quick ratio of 0.73. The stock's 50 day moving average price is $54.87 and its 200-day moving average price is $51.03. The firm has a market cap of $7.02 billion, a P/E ratio of 16.55, a PEG ratio of 0.32 and a beta of 1.44. Olin has a twelve month low of $41.71 and a twelve month high of $60.60.

Olin (NYSE:OLN - Get Free Report) last released its earnings results on Thursday, January 25th. The specialty chemicals company reported $0.30 earnings per share for the quarter, topping analysts' consensus estimates of $0.20 by $0.10. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.50 billion. Olin had a return on equity of 18.44% and a net margin of 6.74%. Equities research analysts anticipate that Olin will post 3.75 EPS for the current year.

Olin Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Thursday, March 7th were paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date was Wednesday, March 6th. Olin's dividend payout ratio (DPR) is presently 22.60%.

Insider Transactions at Olin

In other news, CEO Scott Mcdougald Sutton sold 48,896 shares of the company's stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $52.39, for a total value of $2,561,661.44. Following the transaction, the chief executive officer now directly owns 90,327 shares of the company's stock, valued at $4,732,231.53. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CEO Scott Mcdougald Sutton sold 48,896 shares of the company's stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $52.39, for a total value of $2,561,661.44. Following the transaction, the chief executive officer now directly owns 90,327 shares of the company's stock, valued at $4,732,231.53. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Valerie A. Peters sold 71,800 shares of the company's stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $52.52, for a total transaction of $3,770,936.00. Following the completion of the sale, the vice president now owns 19,469 shares of the company's stock, valued at $1,022,511.88. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 753,274 shares of company stock valued at $40,434,124. 1.80% of the stock is owned by insiders.

Institutional Investors Weigh In On Olin

A number of large investors have recently bought and sold shares of OLN. HighTower Advisors LLC boosted its holdings in Olin by 10.4% in the first quarter. HighTower Advisors LLC now owns 7,760 shares of the specialty chemicals company's stock worth $407,000 after purchasing an additional 728 shares in the last quarter. Private Advisor Group LLC bought a new stake in Olin during the first quarter valued at about $230,000. Acadian Asset Management LLC bought a new stake in Olin during the first quarter valued at about $53,000. Great West Life Assurance Co. Can boosted its holdings in Olin by 8.7% during the first quarter. Great West Life Assurance Co. Can now owns 82,375 shares of the specialty chemicals company's stock valued at $4,437,000 after acquiring an additional 6,589 shares during the period. Finally, U.S. Capital Wealth Advisors LLC boosted its holdings in Olin by 5.8% during the first quarter. U.S. Capital Wealth Advisors LLC now owns 4,714 shares of the specialty chemicals company's stock valued at $246,000 after acquiring an additional 259 shares during the period. 88.67% of the stock is currently owned by institutional investors.

About Olin

Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents.